It was found that an increase in tumor infiltrating lymphocytes (TIL) was associated with low expression of ST6GAL1 in epidermal growth factor receptor 2-overexpressing (HER2) breast cancers and by high expression of ST6GAL2 in triple-negative breast cancers [132]. This evidence concerns the gene ST6GAL1 and breast cancer.